400 related articles for article (PubMed ID: 22462204)
1. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
Wkly Epidemiol Rec; 2012 Mar; 87(11):97-108. PubMed ID: 22462204
[No Abstract] [Full Text] [Related]
2. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
Wkly Epidemiol Rec; 2013 Mar; 88(11):117-25. PubMed ID: 23544238
[No Abstract] [Full Text] [Related]
3. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
Wkly Epidemiol Rec; 2012 Oct; 87(42):401-12. PubMed ID: 23113329
[No Abstract] [Full Text] [Related]
4. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
Wkly Epidemiol Rec; 2014 Mar; 89(11):105-15. PubMed ID: 24707515
[No Abstract] [Full Text] [Related]
5. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
Wkly Epidemiol Rec; 2013 Oct; 88(42):449-63. PubMed ID: 24159668
[No Abstract] [Full Text] [Related]
6. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
Wkly Epidemiol Rec; 2011 Oct; 86(43):469-80. PubMed ID: 22046595
[No Abstract] [Full Text] [Related]
7. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
Wkly Epidemiol Rec; 2015 Mar; 90(12):109-20. PubMed ID: 25796641
[No Abstract] [Full Text] [Related]
8. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
Wkly Epidemiol Rec; 2018 Mar; 93(12):142-52. PubMed ID: 29569430
[No Abstract] [Full Text] [Related]
9. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
Wkly Epidemiol Rec; 2015 Oct; 90(42):561-71. PubMed ID: 26477059
[No Abstract] [Full Text] [Related]
10. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
Wkly Epidemiol Rec; 2014 Oct; 89(42):457-64. PubMed ID: 25337626
[No Abstract] [Full Text] [Related]
11. Antigenic and genetic characteristics of influenza A(H5N1) and influenza A(H9N2) viruses for development of candidate vaccines viruses for pandemic preparedness - February 2011.
Wkly Epidemiol Rec; 2011 Mar; 86(11):93-100. PubMed ID: 21395189
[No Abstract] [Full Text] [Related]
12. Zoonotic influenza viruses: antigenic and genetic characteristics and development of candidate vaccine viruses for pandemic preparedness.
Wkly Epidemiol Rec; 2016 Oct; 91(42):485-99. PubMed ID: 27766828
[No Abstract] [Full Text] [Related]
13. Zoonotic influenza viruses: antigenic and genetic characteristics and development of candidate vaccine viruses for pandemic preparedness.
Wkly Epidemiol Rec; 2017 Mar; 92(12):129-44. PubMed ID: 28337863
[No Abstract] [Full Text] [Related]
14. Zoonotic influenza viruses: antigenic and genetic characteristics and development of candidate vaccine viruses for pandemic preparedness.
Wkly Epidemiol Rec; 2016 Mar; 91(11):133-43. PubMed ID: 26995804
[No Abstract] [Full Text] [Related]
15. Preparing for a potential A(H7N9) pandemic: lessons from the deployment of A(H1N1) pandemic vaccines.
Nguyen-Van-Tam JS; Sellwood C
Expert Rev Vaccines; 2013 Aug; 12(8):825-8. PubMed ID: 23984955
[No Abstract] [Full Text] [Related]
16. Antigenic and genetic characteristics of influenza A(H5N1) and influenza A(H9N2) viruses and candidate vaccine viruses developed for potential use in human vaccines - February 2010.
Wkly Epidemiol Rec; 2010 Mar; 85(11):100-7. PubMed ID: 20229648
[No Abstract] [Full Text] [Related]
17. Zoonotic influenza viruses: antigenic and genetic characteristics and development of candidate vaccine viruses for pandemic preparedness.
Wkly Epidemiol Rec; 2017 Oct; 92(42):633-47. PubMed ID: 29052410
[No Abstract] [Full Text] [Related]
18. Antigenic and genetic characteristics of influenza A(H5N1) viruses and candidate vaccine viruses developed for potential use in human vaccines.
Wkly Epidemiol Rec; 2009 Oct; 84(41):432-6. PubMed ID: 19817020
[No Abstract] [Full Text] [Related]
19. Influenza gain-of-function experiments: their role in vaccine virus recommendation and pandemic preparedness.
Schultz-Cherry S; Webby RJ; Webster RG; Kelso A; Barr IG; McCauley JW; Daniels RS; Wang D; Shu Y; Nobusawa E; Itamura S; Tashiro M; Harada Y; Watanabe S; Odagiri T; Ye Z; Grohmann G; Harvey R; Engelhardt O; Smith D; Hamilton K; Claes F; Dauphin G
mBio; 2014 Dec; 5(6):. PubMed ID: 25505124
[TBL] [Abstract][Full Text] [Related]
20. Use of highly pathogenic avian influenza A(H5N1) gain-of-function studies for molecular-based surveillance and pandemic preparedness.
Davis CT; Chen LM; Pappas C; Stevens J; Tumpey TM; Gubareva LV; Katz JM; Villanueva JM; Donis RO; Cox NJ
mBio; 2014 Dec; 5(6):. PubMed ID: 25505125
[No Abstract] [Full Text] [Related]
[Next] [New Search]
